Treatment for obesity must be continual
Tags: OBESITY -- Treatment
Related Articles
- Obesity research continues to spring leaks. Harper, Mary-Ellen // Clinical & Investigative Medicine;Aug97, Vol. 20 Issue 4, p239
Evaluates the role of the uncoupling protein 1 in obesity. Discovery of the uncoupling protein 2; Importance of brown adipose tissue (BAT) in energy balance and obesity development; Potential of B3-adrenergic agonists on awakening BAT thermogenesis; Reported cloning of a third uncoupling protein.
- Market savvy. Horton, Kathleen // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p158
Focuses on the report `Therapeutic Approaches to the Treatment of Obesity,' which examines the market conditions for weight-reducing pharmaceuticals. Key issues in developing novel anti-obesity agents; Other contents of the report; Contact information.
- Management of obesity: Medical treatment options. Carek, Peter J.; Sherer, Jeffrey T. // American Family Physician;02/01/97, Vol. 55 Issue 2, p551
Discusses the medical treatment options available in the management of obesity in the United States (US). Estimated number of adults that are overweight in the US; Treatments that have been used in the management of obesity with varying degrees of success; Risk factors that obesity is...
- Sibutramine for the treatment of obesity. // American Family Physician;03/15/98, Vol. 57 Issue 6, p1434
Focuses on sibutramine which has been approved for the treatment of obesity by the United States Food and Drug Administration. Information on sibutramine; Details on clinical trials administering the drug to persons who were on a reduced-calorie diet; Common side effect associated with sibutramine.
- Sibutramine not advised for treatment of obesity. Apgar, Barbara // American Family Physician;8/1/98, Vol. 58 Issue 2, p542
Gives information on an article by consultants at Medical Letter in the March, 1998 `Medical Letter on Drugs and Therapeutics' journal, pertaining to the treatment of obesity.
- New fat fighter? // Current Health 1;Dec95, Vol. 19 Issue 4, p2
Reports on Rockefeller University scientists' discovery of a hormone called leptin that is naturally present in mice and humans. Use of extra doses of leptin to treat obese mice; Amount of body weight lost by the mice in two weeks.
- How will you handle sibutramine? Xenakis, Alan // Cortlandt Forum;02/25/98, Vol. 11 Issue 2, p71
Focuses on the effectiveness of meridia, an obesity drug which suppresses the appetite by blocking the reuptake of norepinephrine and serotonin. Average weight loss on ten milligram dosage; Significant weight loss for patients during the first six months of treatment.
- Back to basics: Three squares a day. // Environmental Nutrition;Nov92, Vol. 15 Issue 11, p3
Reports that the best way to lose weight is to go back to eating three square meals a day instead of skipping meals or eating five to six small meals a day. Effects of skipping meals; Small meals.
- Weight loss for obese people: What works? // HealthFacts;Jan97, Vol. 22 Issue 1, p3
Focuses on the declaration of obesity as a chronic disease to be treated with drugs. Results of a review of studies in which participants underwent drug and/or behavioral therapy; Warning against people embarking on drug therapy; Potential side effects.
- Higher treatment standards needed. Chase, Becky // Healthy Weight Journal;Jul/Aug94, Vol. 8 Issue 4, p71
Calls for higher standards in the treatment of obesity. Health risks; Ineffective treatment; Harmful dieting; Epidemic eating disorders; Prejudice against obesity; Industry regulation.
